// App-Quantinova.ai

577 : A meta-analysis of randomzied controlled trials comparing the effect of neoadjuvant chemotherapy with or without bevacizumab (Bev) in the treatment of breast cancer (BC).

Researchers

Presenter

  • Zeina A. Nahleh

Principal Investigators

  • Christopher Dodoo

  • Alok kumar Dwivedi

  • Gehan Botrus

Medical Centers

  • Texas Tech University HSC, El Paso, TX

  • Texas Tech University Health Sciences Center, Texas, TX

  • Texas Tech University Health Sciences Center, Texas, TX

  • Texas Tech University Health Sciences Center, Texas, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved